Alcohol consumption is one of the few modifiable risk factors for breast cancer ([Singletary and Gapstur, 2001](#bib13){ref-type="other"}; [Collaborative Group on Hormonal Factors in Breast Cancer, 2002](#bib7){ref-type="other"}), and we also observed a dose-dependent effect of alcohol intake on breast cancer risk in a case--control study of women up to age 50 years in Germany ([Kropp *et al*, 2001](#bib9){ref-type="other"}). However, drinking behaviour as well as susceptibility to alcohol-induced carcinogenesis may be influenced by individual genetic make-up. In this context, class I alcohol dehydrogenases (ADHs), which are important enzymes in the major pathway of alcohol metabolism *in vivo* and are expressed in normal mammary epithelium ([Triano *et al*, 2003](#bib15){ref-type="other"}), may be relevant. The alcohol dehydrogenase 1B (*ADH1B*) gene (formerly called *ADH2*) exhibits genetic polymorphisms resulting in altered functional and catalytic properties *in vitro* ([Agarwal, 2001](#bib1){ref-type="other"}). A strongly increased oxidation capability has been associated with the *\*2* allele ([Bosron *et al*, 1983](#bib4){ref-type="other"}; [Eriksson *et al*, 2001](#bib8){ref-type="other"}), an Arg47His substitution with reported allele frequencies ranging between 0 and 6.8% in Europeans ([Brennan *et al*, 2004](#bib5){ref-type="other"}).

Previously, a significant inverse association between the *ADH1B\*2* allele and frequency of alcohol consumption was observed in a case-only study ([Sturmer *et al*, 2002](#bib14){ref-type="other"}). We employed a population-based case--control study of women up to age 50 years to examine the potential effect of *ADH1B* genotype on the association between alcohol consumption and breast cancer risk.

MATERIALS AND METHODS
=====================

Study subjects and data collection
----------------------------------

A detailed description of the underlying case--control study has been provided elsewhere ([Chang-Claude *et al*, 2000](#bib6){ref-type="other"}). Patients up to age 50 years with a diagnosis of primary incident *in situ* or invasive breast cancer were recruited between 1 January 1992 and 31 December 1995. Controls were selected randomly from lists of residents supplied by population registries; for each patient, two controls were matched according to exact age and study region. Written informed consent from all participants was obtained. The study was approved by the ethics committee of the University of Heidelberg.

In total, 706 (70.2%) women of the 1005 breast cancer patients who were alive when identified completed the study questionnaire. Of all 2257 eligible controls, 1381 (61.2%) participated. Detailed information on demographic characteristics and various risk factors was elicited by means of a self-administered questionnaire. Alcohol consumption was assessed for three time periods, that is, 15--20, 20--30 and 30--50 years, and for different types of beverages (beer, wine, aperitifs, liquor and spirits). The detailed method for the calculation of average daily alcohol intake has been described previously ([Kropp *et al*, 2001](#bib9){ref-type="other"}).

Menopausal status was defined as the reported state half a year before the reference date, which was the date of diagnosis for cases and the date of completion of the questionnaire for controls. The status of women with previous hysterectomy not accompanied by bilateral oophorectomy was classified as unknown.

The present analysis was restricted to 613 cases and 1082 controls with at least one parent of German nationality and who could be successfully genotyped (three and five failures, respectively).

Genotyping *ADH1B* by TaqMan PCR
--------------------------------

Genomic DNA was extracted from peripheral blood using the QIAamp DNA Blood Kit (Qiagen, Hilden, Germany). Primer and hybridisation probes were designed with Primer Express. Sense primer 5′-CTCTTTATTCTGTAGATGGTGGCTGTAG-3′ and antisense primer 5′-GGGTCACCAGGTTGCCACTA-3′ were used to amplify a 76 bp fragment containing the G47A polymorphism of the *ADH1B* gene. Two minor-groove-binding (MGB) DNA probes were synthesised. The probe corresponding to the wild type (5′-FAM-TCTGTCGCACAGATG-MGB-3′) was labelled with 6-FAM, and the probe corresponding to the mutation (5′-VIC-AATCTGTCACACAGATGA-MGB-3′) was labelled with VIC at the 5′-end. The genotypes were analysed in software 'Sequence Detector\' version 1.7 by procedure allelic discrimination after PCR.

Amplification was performed in a final volume of 25 *μ*l containing 40 ng of DNA, 300 n[M]{.smallcaps} of each primer, 200 n[M]{.smallcaps} of each probe and 12.5 *μ*l of TaqMan Universal PCR Master Mix (Perkin-Elmer, Weiterstadt, Germany).

In every assay, negative controls as well as controls for the wild type, mutant type and heterozygote were included. The PCR conditions were as follows: 2 min at 50°C plus 95°C for 10 min, followed by 40 cycles of denaturation at 92°C for 15 s, annealing and extension in one step at 60°C for 1 min. Genotyping was performed blinded to case--control status of the blood sample providers.

Statistical analysis
--------------------

*χ*^2^ tests were used to assess deviation from Hardy--Weinberg equilibrium. Multivariate conditional logistic regression analysis with 5-year age strata was carried out using the PHREG procedure of the statistical software package SAS release 8.2 (SAS Institute, Cary, NC, USA).

In the multivariate model, we included several relevant variables influencing breast cancer risk (see [Table 2](#tbl2){ref-type="table"}). Variables that did not alter the estimates substantially, such as study region, body mass index, use of oral contraceptives and age at menarche, were not included in the analyses presented. Statistical interaction between *ADH1B* genotype and alcohol consumption was tested by using multiplicative interaction terms and evaluated by the likelihood ratio test.

RESULTS
=======

Selected characteristics of the study population are depicted in [Table 1](#tbl1){ref-type="table"}. In all, 65 breast cancer patients (10.6%) and 109 controls (10.1%) were heterozygous or homozygous carriers of the *ADH1B\*2* allele, corresponding to allele frequencies of 0.06 and 0.05, respectively. The distribution of *ADH1B* genotypes was in Hardy--Weinberg equilibrium (*P*=0.4 for cases and *P*=0.6 for controls).

We did not observe an association between *ADH1B* genotype and several risk factors, including first-degree family history of breast cancer, body mass index, parity, breastfeeding or smoking status (data not shown). However, alcohol consumption was found to differ significantly by *ADH1B* genotype among controls, with a mean average daily alcohol intake of 7.2 g (standard deviation (s.d.) 9.1) in women with *ADH1B\*1/\*1* genotype and 5.8 g (s.d. 7.8) in carriers of the *\*2* allele (Wilcoxon\'s rank-sum test *P*=0.01). Results were virtually identical when all study subjects were considered (data not shown).

The analysis revealed no main effect of *ADH1B* genotype on breast cancer risk (adjusted OR for carriers of *ADH1B\*2* allele *vs ADH1B\*1/\*1* genotype being 1.0, 95% confidence interval (CI) 0.7--1.4). However, multivariate analysis separately for carriers and noncarriers of the *ADH1B\*2* allele yielded differences in breast cancer risk associated with increasing levels of alcohol intake ([Table 2](#tbl2){ref-type="table"}). Among carriers of the *\*2* allele, there was a significant decreasing trend in breast cancer risk with increasing alcohol consumption (*P*-value for linear trend 0.04), although the odds ratio (OR) was significant only for the category of 12 g or more alcohol per day. In contrast, among women with *ADH1B\*1/\*1* genotype, breast cancer risk increased with increasing alcohol consumption (*P*=0.03). The interaction between *ADH1B* genotype and alcohol intake was borderline statistically significant for the highest category of alcohol consumption (*P*=0.05) but not for low or moderate levels.

DISCUSSION
==========

Our data raise the possibility of an effect modification of the association between alcohol consumption and breast cancer risk by *ADH1B* genotype in our study population, which was apparent only at the highest consumption category of 12 g or more alcohol per day. We showed previously that breast cancer risk increased significantly with high daily alcohol intake of ⩾19 g in this study population ([Kropp *et al*, 2001](#bib9){ref-type="other"}). Owing to the small number of *ADH1B\*2* carriers, we were not able to further subdivide the highest alcohol intake category of ⩾12 g day^−1^. Corresponding to a previous case-only study ([Sturmer *et al*, 2002](#bib14){ref-type="other"}), a case-only analysis of our data would yield a statistically significant interaction OR (OR 0.2, 95% CI 0.1--0.6 for ⩾12 g alcohol day^−1^). However, since *ADH1B* genotype and alcohol intake are not independent in our study population, the modifying effect of the *ADH1B* genotype on breast cancer risk associated with alcohol consumption is overestimated in the case-only analysis, partly due to residual confounding by differences in alcohol consumption caused by the genotype ([Albert *et al*, 2001](#bib2){ref-type="other"}). Indeed, indications for an association between *ADH1B* genotype and alcohol consumption, alcoholism or adverse reactions such as flushing were observed in previous studies ([Whitfield *et al*, 1998](#bib16){ref-type="other"}; [Borras *et al*, 2000](#bib3){ref-type="other"}; [Loew *et al*, 2003](#bib10){ref-type="other"}; [Neumark *et al*, 2004](#bib12){ref-type="other"}).

There is still controversy in the literature regarding the effect of *ADH1B* genotype on alcohol pharmacokinetics *in vivo.* Most studies failed to detect differences in blood alcohol or acetaldehyde levels by *ADH1B* genotype ([Yamamoto *et al*, 1993](#bib18){ref-type="other"}; [Mizoi *et al*, 1994](#bib11){ref-type="other"}; [Whitfield *et al*, 2001](#bib17){ref-type="other"}); only one recent study reported a significantly higher alcohol elimination rate in carriers of the *ADH1B\*2* allele ([Neumark *et al*, 2004](#bib12){ref-type="other"}).

The reduction in breast cancer risk associated with high consumption levels in carriers of the *ADH1B\*2* allele in our study could therefore be explained by a higher alcohol elimination rate in these subjects. Owing to the low allele frequency of the *ADH1B\*2* allele in Caucasians, our study had limited power to detect a gene--environment interaction for high alcohol consumption levels and our findings about *ADH1B* genotype as an effect modifier of breast cancer risk associated with high alcohol consumption need confirmation in larger studies.
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###### 

Selected characteristics of the study population

                                                 **Cases(*n*=613)**   **%**   **Controls(*n*=1082)**   **%**   ***P*-value^a^**
  ---------------------------------------------- -------------------- ------- ------------------------ ------- ------------------
  Mean age (s.d.)                                42.4 (5.8)                   42.6 (5.7)                        
                                                                                                                
  *Menopausal status*                                                                                          
   Premenopausal                                 483                  78.8    874                      80.8     
   Postmenopausal                                34                   5.6     67                       6.2      
   Unknown                                       96                   15.7    141                      13.0    0.30
                                                                                                                
  *First-degree family history*                                                                                
   No                                            536                  87.4    1024                     94.6     
   Yes                                           77                   12.6    58                       5.4     \<0.01
                                                                                                                
  *Parity*                                                                                                     
   0                                             136                  22.2    228                      21.1     
   1--2 children                                 414                  67.5    680                      62.9     
   3+ children                                   63                   10.3    174                      16.1    \<0.01
                                                                                                                
  *Breastfeeding*^b^                                                                                           
   0                                             153                  32.1    247                      28.9     
   1--12 months                                  289                  60.6    501                      58.7     
   12+ months                                    35                   7.3     106                      12.4    0.01
                                                                                                                
  *Education*                                                                                                  
   Low                                           80                   13.1    149                      13.8     
   Intermediate                                  412                  67.2    679                      62.8     
   High                                          121                  19.7    254                      23.5    0.15
                                                                                                                
  *Smoking*                                                                                                    
   Never active                                  271                  44.2    515                      47.6     
   Former smoker                                 132                  21.5    258                      23.8     
   Current smoker                                210                  34.3    309                      28.6    0.05
                                                                                                                
  *Alcohol consumption (g day on average^−1^)*                                                                 
   0                                             117                  19.1    176                      16.3     
   1--5                                          233                  38.0    454                      42.0     
   6--11                                         113                  18.4    239                      22.1     
   12+                                           150                  24.5    213                      19.7    0.02
                                                                                                                
  *ADH1B genotypes*                                                                                            
   *\*1/\*1*                                     548                  89.4    973                      89.9     
   *\*1/\*2*                                     62                   10.1    107                      9.9      
   *\*2/\*2*                                     3                    0.5     2                        0.2     0.53^c^

s.d.=standard deviation; *ADH1B*=alcohol dehydrogenase 1B.

*χ*^2^ test used.

Among parous women only.

Fisher\'s exact test used.

###### 

ORs for breast cancer risk associated with alcohol intake stratified by *ADH1B* genotype

                                                  ***ADH1B\*1/\*1* genotype**   ***ADH1B\*2* carrier**                                 
  ---------------------------------------------- ----------------------------- ------------------------ ------------ ------- --------- ------------
  *Alcohol consumption (g day on average^−1^)*                                                                                         
   0                                                        101/147                    1 (Ref)                        16/29   1 (Ref)        
   1--5                                                     200/407                      0.74            0.54--1.01   33/47    0.81     0.34--1.91
   6--11                                                    104/226                      0.70            0.49--0.99   9/13     0.87     0.25--3.02
   12+                                                      143/193                      1.12            0.78--1.59   7/20     0.29     0.08--1.00
   *P*-value for trend^b^                                                                0.03                                  0.04          

*ADH1B*=alcohol dehydrogenase 1B; OR=odds ratio; CI=confidence interval.

ORs stratified for age by 5-year intervals; additional adjustment was made for first-degree family history (yes/no), parity (0, 1--2, 3+ children), menopausal status (pre-, postmenopausal, unknown), education (low, intermediate and high) and smoking status (never, former and current active smoking) as categorical variables and breastfeeding (total duration in months) as continuous variable;

Test for linear trend (mean of categories used).
